CAS 15959-53-2

Sulfamide, phenyl-

Description:

Sulfamide, phenyl- is an organic compound characterized by the presence of a sulfonamide functional group attached to a phenyl ring. This compound typically exhibits properties associated with sulfonamides, including potential antibacterial activity due to its ability to inhibit bacterial folic acid synthesis. It is generally a white to off-white solid that is soluble in polar solvents, such as water and alcohols, but may have limited solubility in non-polar solvents. The presence of the phenyl group contributes to its aromatic characteristics, influencing its reactivity and interaction with biological systems. Sulfamide, phenyl- may be utilized in various chemical syntheses and has applications in medicinal chemistry, particularly in the development of pharmaceuticals. Safety data indicates that, like many sulfonamides, it should be handled with care due to potential allergic reactions and toxicity in certain contexts. Overall, sulfamide, phenyl- is a compound of interest in both industrial and research settings, particularly in the fields of organic synthesis and medicinal chemistry.

Formula: C₆H₈N₂O₂S

Sulfamide, N-phenyl-

CAS: 15959-53-2

Formula: C₆H₈N₂O₂S

Purity: 95%

Color and Shape: Solid

Molecular weight: 172.2049

Ref: IN-DA001R79

N-Phenylaminosulphonamide

CAS: 15959-53-2

N-Phenylaminosulphonamide

Purity: 95%

Color and Shape: Solid

Molecular weight: 172.20g/mol

Ref: 54-OR54584

Phenylsulfamide

CAS: 15959-53-2

Phenylsulfamide (Compound 10), acting as an inhibitor of human carbonic anhydrase-II (hCA-II), exhibits a dissociation constant (Kd) of 45.50 μM and an

Formula: C₆H₈N₂O₂S

Color and Shape: Solid

Molecular weight: 172.2

Ref: TM-T74587

N-Phenylaminosulfonamide

CAS: 15959-53-2

N-Phenylaminosulfonamide is a prodrug that is metabolized in the body to release oxadiazole. It has been shown to lower intracellular calcium levels by targeting response elements and hydrogen bonds in the cell. N-Phenylaminosulfonamide also inhibits fatty acid synthesis, which may be due to its ability to inhibit 3t3-l1 preadipocytes. The drug has been shown to have an anti-obesity effect by inhibiting energy metabolism through inhibition of hydroxyl group oxidation, leading to reduced glucose uptake and glycolysis.

Formula: C₆H₈N₂O₂S

Purity: Min. 95%

Molecular weight: 172.21 g/mol

Ref: 3D-QAA95953